Ex-vivo expanded human CD3+ CD56+ T cells produce cytokines of the T helper 1 (TH1) type and have broad non-MHC-restricted cytotoxicity against a variety of tumor cell lines as well as autologous and allogeneic fresh tumor isolates [3]. This evidence concerns the gene NCAM1 and neoplasm.